Health TrialsbyHealthPanel

Optimizing Strategies to Maximize Patient Recruitment Yield

ConditionRecruitment
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorEmory University

About this trial

This platform trial aims to evaluate the effectiveness of different messaging strategies within a MyChart messaging program for research recruitment. MyChart is a patient portal system within the Electronic Medical Record (EMR), and messages can be sent directly to patients about research opportunities.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

All studies using the MyChart recruitment service are eligible, including both clinical trials and observational studies.

Not using MyChart for recruitment.

At least 500 messages sent, 125 for each arm

All patients receiving messages via MyChart will be included

Disqualifiers

Minor

Excluded from primary study that is recruiting participants.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Baseline (control) message

    Behavioral

    The MyChart study recruitment program will send a message based on the current template, which is a brief message with a neutral tone.

  • Positively-valenced message

    Behavioral

    The MyChart study recruitment program will send a message based on a template that contains positively-valenced language related to the value/importance of the study.

  • Payment-inclusive message

    Behavioral

    The MyChart study recruitment program will send a message based on a template that includes more detailed information about participant payment.

  • Positively-valenced, payment-inclusive message

    Behavioral

    The MyChart study recruitment program will send a message based on a template that includes both positively-valenced language and detailed information about participant payment.

Treatment groups

100,000 Participants
are divided into 4 treatment groups
Group A: Baseline (control) messageActive comparator 1 intervention
Group B: Positively-valenced messageExperimental treatment 1 intervention
Group C: Payment-inclusive messageExperimental treatment 1 intervention
Group D: Positively-valenced, payment-inclusive messageExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Rate of "interested" response to recruitment messages

The primary endpoint is the rate at which individuals respond that they are interested in participating in the study to which they are invited. The primary outcome is a binary variable of "interested" response.

Time frame
Month 12

Secondary outcomes

1

Rate of non-response

This study will examine the rate of non-response to recruitment messages.

Time frame
Month 12
2

Rate of "not interested" responses

This study will examine the rate of individuals responding that they are not interested in the study.

Time frame
Month 12
3

Rate of change in MyChart permissions to contact

This study will examine the rate at which individuals exposed to a MyChart recruitment message change their permission settings for contact about research opportunities.

Time frame
Month 12
4

Rate of enrollment among "interested" patients

Study teams whose study invitations are used in this trial will be contacted about the rate of enrollment among patients who responded as "interested" to the message.

Time frame
Month 12

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Emory University

Lead sponsor

American Heart Association

Collaborator

Georgia Clinical & Translational Science Alliance

Collaborator

National Center for Advancing Translational Sciences (NCATS)

Collaborator

Source ClinicalTrials.gov
Apply now